LMO3 downregulation in PCa: A prospective biomarker associated with immune infiltration

Prostate cancer is the third leading cause of new cancer cases and the second most common tumor type in men globally. LMO3 has been stated to play a vital role in some cancers; however, the prognostic value of LMO3 in PCa remains vague. Here, we utilized various web databases to elucidate in detail...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Wenchao, Sun, Taotao, Wang, Jiaxin, Li, Hao, Chen, Bingliang, Zhou, Yingjian, Wang, Tao, Wang, Shaogang, Liu, Jihong, Jiang, Hongyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527341/
https://www.ncbi.nlm.nih.gov/pubmed/36199576
http://dx.doi.org/10.3389/fgene.2022.945151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527341/
https://www.ncbi.nlm.nih.gov/pubmed/36199576
http://dx.doi.org/10.3389/fgene.2022.945151

Ejemplares similares